Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocky9 who wrote (13203)	9/29/2004 3:59:00 PM
From: Rudy Saucillo	Read Replies (1) of 52153

See Peter's post #12961 with the following updates: AGIX: Final top line results for AGI-1061 due by year end. DSCO: PhII results of Surfaxin in ARDS due in 4th quarter. PARS: PhIIa results of Dexanabinol in CAGB due end of Nov. Pivotal PhIII results of Dex in TBI due around end of Dec., possibly early '05. Re. PARS, wild trading is going on today. But I doubt that there are any credible rumors about either of the trials. I would guess this is an institution selling or a similar type activity. Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next